Metformin discontinuation in patients beginning second-line glucose-lowering therapy: results from the global observational DISCOVER study programme

OBJECTIVES: To evaluate the extent to which patients with type 2 diabetes discontinue metformin therapy when initiating second-line treatment and factors associated with metformin discontinuation, using baseline data from the DISCOVER study programme. DESIGN: DISCOVER is a 3-year, prospective, obser...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMJ Open
Autors principals: Khunti, Kamlesh, Gomes, Marilia B, Kosiborod, Mikhail, Nicolucci, Antonio, Pocock, Stuart, Rathmann, Wolfgang, Shestakova, Marina V, Shimomura, Iichiro, Watada, Hirotaka, Chen, Hungta, Cid-Ruzafa, Javier, Fenici, Peter, Hammar, Niklas, Tang, Fengming, Ji, Linong
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2020
Matèries:
Diabetes and Endocrinology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7462233/
https://ncbi.nlm.nih.gov/pubmed/32868349
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2019-034613
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars